Glutaric acidemia IIc: genes and variants
Explore variant evidence for Glutaric acidemia IIc across 2 analyzed proteins (ETFDH, ETFA). Linked ClinVar records include 54 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 13 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Glutaric acidemia IIc
ETFDH: Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial
It transfers electrons from electron-transfer flavoprotein to ubiquinone in the inner mitochondrial membrane, linking several dehydrogenases to the respiratory chain. Biallelic deficiency causes multiple acyl-CoA dehydrogenase deficiency, often with a riboflavin-responsive late-onset myopathic form.
51 ClinVar pathogenic / likely pathogenic and 16 uncertain variants in ETFDH have source records linked to Glutaric acidemia IIc. Association strength is not clinical gene validity.
ETFA: Electron transfer flavoprotein subunit alpha, mitochondrial
A subunit of mitochondrial electron-transfer flavoprotein, which carries electrons from fatty-acid and amino-acid breakdown enzymes to the respiratory chain through ETFDH. Pathogenic variants can cause multiple acyl-CoA dehydrogenase deficiency.
3 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in ETFA have source records linked to Glutaric acidemia IIc. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ETFB.
ClinVar pathogenic and likely pathogenic variants linked to Glutaric acidemia IIc
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ETFDH L127H | 127 | Pathogenic / likely pathogenic (★★) | |
| ETFDH L127P | 127 | Pathogenic / likely pathogenic (★★) | |
| ETFDH R175L | 175 | Pathogenic / likely pathogenic (★★) | |
| ETFDH R175H | 175 | Pathogenic / likely pathogenic (★★) | |
| ETFDH G611R | 611 | Pathogenic / likely pathogenic (★★) | |
| ETFDH R175C | 175 | Pathogenic / likely pathogenic (★★) | |
| ETFDH G611E | 611 | Pathogenic / likely pathogenic (★★) | |
| ETFDH S82P | 82 | Pathogenic / likely pathogenic (★★) | |
| ETFDH R358K | 358 | Pathogenic / likely pathogenic (★★) | |
| ETFDH Y361C | 361 | Pathogenic / likely pathogenic (★★) | |
| ETFDH M404T | 404 | Pathogenic / likely pathogenic (★★) | |
| ETFDH G467R | 467 | Intramembrane | Pathogenic / likely pathogenic (★★) |
| ETFDH H529R | 529 | Pathogenic / likely pathogenic (★★) | |
| ETFA T266M | 266 | Domain II | Pathogenic / likely pathogenic (★★) |
| ETFDH D130V | 130 | Pathogenic / likely pathogenic (★★) | |
| ETFDH L138R | 138 | Pathogenic / likely pathogenic (★★) | |
| ETFDH L176F | 176 | Pathogenic / likely pathogenic (★★) | |
| ETFDH L334P | 334 | Pathogenic / likely pathogenic (★★) | |
| ETFDH P456S | 456 | Pathogenic / likely pathogenic (★★) | |
| ETFDH P456L | 456 | Pathogenic / likely pathogenic (★★) | |
| ETFDH G472R | 472 | Intramembrane | Pathogenic / likely pathogenic (★★) |
| ETFDH P483L | 483 | Intramembrane | Pathogenic / likely pathogenic (★★) |
| ETFDH W484R | 484 | Intramembrane | Pathogenic / likely pathogenic (★★) |
| ETFDH G610R | 610 | Pathogenic / likely pathogenic (★★) | |
| ETFDH V174A | 174 | Pathogenic / likely pathogenic (★★) | |
| ETFDH P227T | 227 | Pathogenic / likely pathogenic (★★) | |
| ETFDH Y333C | 333 | Pathogenic / likely pathogenic (★★) | |
| ETFDH G356E | 356 | Pathogenic / likely pathogenic (★★) | |
| ETFDH L377P | 377 | Pathogenic / likely pathogenic (★★) | |
| ETFDH L409F | 409 | Pathogenic / likely pathogenic (★★) | |
| ETFDH T485S | 485 | Pathogenic / likely pathogenic (★★) | |
| ETFA G116R | 116 | Domain I | Pathogenic / likely pathogenic (★★) |
| ETFA R122K | 122 | Domain I | Pathogenic / likely pathogenic (★★) |
| ETFDH M1T | 1 | Pathogenic / likely pathogenic (★★) | |
| ETFDH M1I | 1 | Pathogenic / likely pathogenic (★★) | |
| ETFDH S35P | 35 | Pathogenic / likely pathogenic (★★) | |
| ETFDH R99C | 99 | Pathogenic / likely pathogenic (★★) | |
| ETFDH R155G | 155 | Intramembrane | Pathogenic / likely pathogenic (★★) |
| ETFDH A215T | 215 | Pathogenic / likely pathogenic (★★) | |
| ETFDH E246K | 246 | Pathogenic / likely pathogenic (★★) | |
| ETFDH Y257C | 257 | Pathogenic / likely pathogenic (★★) | |
| ETFDH G272R | 272 | Pathogenic / likely pathogenic (★★) | |
| ETFDH V291G | 291 | Pathogenic / likely pathogenic (★★) | |
| ETFDH G362R | 362 | Pathogenic / likely pathogenic (★★) | |
| ETFDH V451L | 451 | Pathogenic / likely pathogenic (★★) | |
| ETFDH Y553H | 553 | Pathogenic / likely pathogenic (★★) | |
| ETFDH E557K | 557 | Pathogenic / likely pathogenic (★★) | |
| ETFDH E567K | 567 | Pathogenic / likely pathogenic (★★) | |
| ETFDH E185K | 185 | Pathogenic / likely pathogenic (★★) | |
| ETFDH Q222P | 222 | Pathogenic / likely pathogenic (★★) | |
| ETFDH P27S | 27 | Pathogenic / likely pathogenic (★★) | |
| ETFDH S307C | 307 | Pathogenic / likely pathogenic (★★) | |
| ETFDH E193K | 193 | Pathogenic / likely pathogenic (★) | |
| ETFDH A84T | 84 | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Glutaric acidemia IIc
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| ETFDH P227S | 227 | Conflicting reports (★) | +7: in a 3D region that tolerates change poorly (1R); P227T at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.782 | |
| ETFDH G610A | 610 | Uncertain | +6: 3 other pathogenic changes within 3 positions; G610R at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.704 |
Which prediction tools work for Glutaric acidemia IIc
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 90 out of 100
- ESM1b (LLR): 89 out of 100
- AlphaMissense: 86 out of 100
- CADD: 86 out of 100
- PolyPhen-2: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 81 out of 100
- SpliceAI: 46 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 32 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Multiple acyl-CoA dehydrogenase deficiency also has ClinVar records linked to ETFDH variants; they fall partly in the same places as the Glutaric acidemia IIc variants (90 pathogenic / likely pathogenic).
Diseases related to Glutaric acidemia IIc
- Multiple acyl-CoA dehydrogenase deficiency, also linked to ETFA and ETFDH
Frequently asked questions
Which genes have records linked to Glutaric acidemia IIc?
This view contains 2 analyzed proteins: ETFDH, ETFA. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 54 pathogenic or likely pathogenic variants, 8 variants of uncertain significance and 13 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 78 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center